Copyright © 1999 by the European Society of Cardiology.
Differential anti-ischaemic effects of muscarinic receptor blockade in patients with obstructive coronary artery disease. Impaired vs normal left ventricular function
a Sticares Research Foundation, Rotterdam, The Netherlands
b Department of Cardiology/Thoraxcenter, University Hospital Groningen, Groningen, The Netherlands
revised April 27, 1999; accepted April 28, 1999
Abstract
Aims In patients with coronary artery disease acetylcholine (a muscarinic agonist) causes vasoconstriction. The effect of atropine (a muscarinic antagonist) on coronary vasotone in patients with normal or impaired left ventricular function is unknown.
Methods and Results Twenty-four patients who required atropine infusion (to supplement heart rate response) during atrial pacing (pacing was conducted to assess ischaemia as part of an experimental protocol) were studied; 17 patients had normal and seven impaired left ventricular function (ejection fraction
0·40). Two control groups were selected from a large database (from patients in whom atrial pacing was carried out but to whom atropine was not administered) to match the normal (n=20) and dysfunction (n=10) groups. In the normal left ventricular function group atropine increased rate pressure product by 12±4%, as compared to those without atropine (P<0·05). Left ventricular end diastolic pressure increased less in the atropine group (+40±8% vs +78±6%;P<0·05). Arterial norepinephrine increased similarly in both groups, but coronary flow (as assessed by using a thermodiluting method in the coronary sinus) increased 23±4% more in the atropine group (P<0·05). Further, there were lower levels of myocardial lactate production and ST-segment depression in the atropine group [lactate extraction +13±6% (atropine) vs 19±4% (controls), ST-segment depression 1·3±0·6 (atropine) vs 1·8±0·2mm (control), both P<0·05 between groups]. In contrast, in the dysfunction group the overall effect of atropine was less pronounced.
Conclusion In patients with normal left ventricular function atropine improves coronary flow and reduces myocardial lactate production and ST-segment depression during atrial pacing, suggesting a reduction in myocardial ischaemia.
Key Words: Coronary disease, endothelial functionischaemia, muscarinic antagonists
f1 Correspondence: Dr A.F.M. van den Heuvel, Dept. of Cardiology/Thoraxcenter, University Hospital Groningen, P.O. ox 30.001, 9700 RB Groningen, The Netherlands.
References
- Feigl EO. Parasympathetic control of coronary blood flow in dogs. Circ Res. 1969;25:509519
[Abstract/Free Full Text] - Hackett JG, Abboud FM, Mark AL, Schmid PG, Heistad DD. Coronary vascular responses to stimulation of chemoreceptors and baroreceptors. Circ Res. 1972;31:817
[Abstract/Free Full Text] - Ito BR, Feigl EO. Carotid chemoreceptor reflex parasympathetic coronary vasodilation in the dog. AM J Physiol. 1985;249:H11671175
- Denn MJ, Stone HL. Autonomic innervation of dog coronary arteries. J Appl Physiol. 1976;412:3035
- Gerova M, Dolezel S, Gero J, Barta E. Role of the vagus in control of the major conduit artery in the dog. Physiol Bohemoslov. 1979;28:299307
- Cox DA, Hintze TH, Vatner SF. Effects of acetylcholine on large and small coronary arteries in conscious dogs. J Pharmacol Exp Ther. 1983;225:764769
[Abstract/Free Full Text] - Young MA, Knight DR, Vatner SF. Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis. 1987;30:211234[CrossRef][ISI][Medline]
- Brunner F, Kuhlberger E, Schloos J, Kukovetz WR. Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies. Eur J Pharmacol. 1991;196:247255[CrossRef][ISI][Medline]
- Hendriks MGC, Pfaffendorf M, van Zwieten PA. Characterization of the muscarinic receptors in the mesenteric vascular bed of spontaneously hypertensive rats. J Hypertension. 1993;11:13291335[ISI][Medline]
- Ludmer PL, Selwyn AP, Shook TL. Paradoxical vasoconstriction induced y acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:10461051[Abstract]
- Zeiher AM, Drexler H, Wollschläger H, Just H. Preserved flow mediated vasodilation despite acetylcholine-induced vasoconstriction in atherosclerotic coronary arteries in man (Astr). J Am Coll Cardiol. 1989;13:132[ISI][Medline]
- Remme WJ, Van de Berg MD, Mantel M. Temporal relation of changes in regional coronary flow and myocardial lactate and nucleoside metabolism in humans during pacing-induced ischemia. Am J Cardiol. 1986;58:11881194[CrossRef][ISI][Medline]
- Van Den Heuvel AFM, van der Ent M, van Veldhuisen DJ, Kruijssen DACM, Bartels GL, Remme WJ. Effects of epanolol, a selective ß1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction. J Cardiovasc Pharmacol. 1998;31:506512[CrossRef][ISI][Medline]
- van Zwieten PA, Doods HN. Muscarinic receptors and drugs in cardiovascular medicine. Cardiovasc Drugs Ther. 1995;9:159167[CrossRef][ISI][Medline]
- Ganz W, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971;44:181195
[Abstract/Free Full Text] - Grossman W, Baim DS. Cardiac Catheterization, Angiography and Intervention. Philadelphia, London: Lea & Febiger; 1991.
- Maseri A, Crea F, Cianflone D. Myocardial ischemia caused by distal coronary vasoconstriction. Am J Cardiol. 1992;70:16021605[CrossRef][ISI][Medline]
- Marraccini P, Orsini E, Nassi G, L'Abbate A. Effects of parasympathetic blockade on ischemic threshold in patients with exercise-induced myocardial ischemia. Am J Cardiol. 1991;68:539542[CrossRef][ISI][Medline]
- Eckberg DL. Parasympathetic cardiovascular control in human disease: a critical review of methods and results. Am J Physiol. 1980;239:H581593
- Brouwer J, van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, Boomsma F, Haaksma J, Lie KI. Heart rate variability in patients with mild to moderate heart failure: effects of neurohumoral modulation by digoxin and ibopamine. J Am Coll Cardiol. 1995;26:983990[Abstract]
- Vatner SF, Hittinger L. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol. 1993;22:34A40A[Medline]
- Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373376[CrossRef][Medline]
- Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 1988;5:349380
- Endoh M, Hirosawa K, Kaneko N, Hase C, Inoue Y, Konno S. Prinzmetal's variant angina; coronary arteriogram and ventriculogram during attack induced by methacholine. N Engl J Med. 1976;294:252254[Abstract]
- Busse R, Trogish G, Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol. 1985;80:475490[CrossRef][ISI][Medline]
- Nabel EG, Selwin AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990;16:349356[Abstract]
- Baumgart D, Heusch G. Neuronal control of blood flow. Basic Res Cardiol. 1995;90:142159[CrossRef][ISI][Medline]
- Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation. 1997;96:33903395
[Abstract/Free Full Text] - Schroder K, Agrawal R, Voller H, Kursten B, Dissmann R, Schultheiss HP. Factors influencing the diagnostic accuracy of dobutamine stress echocardiography. Int J Card Imaging. 1997;13:493498[CrossRef][ISI][Medline]
- Remme WJ, Kruyssen DACM, Look MP, Bootsma M, De Leeuw PW. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans. J Am Coll Cardiol. 1994;23:8291[Abstract]
- Haunstetter A, Haass M, Yi X, Kruger C, Kubler W. Muscarinic inhibition of cardiac norepinephrine and neuropeptide Y release during ischemia and reperfusion. Am J Physiol. 1994;267:R15521558
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||